Improving the Future of Care for Heart Disease

There have been great strides made in recent years to help treat patients diagnosed with heart disease. As technology improves and new medications are developed it will be important to ensure they can get to the patients who need them most.

It has not been very long since PCSK9 inhibitors were improved but already Jean Marie Cacciabaudo, MD, from the Northwell Health System said she has seen dramatic results in patients. One challenge for this new class of medication has been the cost to some patients. However, Cacciabaudo said some patients have decided the cost is worth it to reduce their cholesterol numbers and improve their overall health. She added that she hopes as more research is done and more is learned about their effectiveness the price will come down allowing more patients to have access to the treatment.